Immune to Cancer: The CRI Blog
-
Patient Immunotherapy Summit: Pancreatic Cancer Brief
Pancreatic cancer is one of the most difficult cancers to treat with immunotherapy and is the third-leading… -
Immunotherapy 101: What is Immunotherapy and How Does it Work?
Jedd Wolchok, MD, PhD, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill… -
CRI’s 7th Annual Patient Immunotherapy Summit – December 2023 Full Cut
The Cancer Research Institute’s 7th Annual Patient Immunotherapy Summit hosts a plethora of impactful information that cancer… -
Unraveling the Pro-Tumorigenic Myelopoiesis Driven by an IL-4 Signaling Axis in Bone Marrow
CRI is delighted to share the latest milestone achievement from CRI-supported investigators at Icahn School of Medicine… -
CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide
A Large Cancer Presence on a Global Scale The Cancer Research Institute (CRI) has a singular focus:… -
How CRI is Taking on Pancreatic Cancer, “The Silent Killer”
Immunotherapy holds the greatest promise for optimizing outcomes for cancer patients, and eventually finding a cure for… -
This is How CRI Funded Scientists are Fighting Breast Cancer
A Global Challenge Breast cancer poses a formidable challenge to healthcare, being one of the most common… -
Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field
iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill… -
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments…